ClinicalTrials.govpublic full text
FT576 in Subjects With Multiple Myeloma
multiple myeloma, myeloma, daratumumab, car nk cell, cellular therapy, relapsed/refractory multiple myeloma, allogeneic natural killer cells, anti-cd38 monoclonal antibody, chimeric antigen receptor (car), bcma, anti-b-cell maturation antigen (bcma), natural killer (nk) cell
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 902434
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.